Basic Information
| LncRNA/CircRNA Name | TAPIR |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | Microarray , RNA-seq, qPCR, Western blot, in vitro knockdown etc. |
| Sample | prostate tissue,cell lines(LNCaP,DU145) |
| Expression Pattern | up-regulated |
| Function Description | TAPIR-1 and -2 Overexpression is Restricted to Tumor Tissue.TAPIR Transcript Knockdown Causes Downregulation of Cell Cycle Genes and Growth Arrest in Prostate Tumor Cells |
| Pubmed ID | 32365858 |
| Year | 2020 |
| Title | The Role of lncRNAs TAPIR-1 and -2 as Diagnostic Markers and Potential Therapeutic Targets in Prostate Cancer. |
External Links
| Links for TAPIR | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |